Month: July 2024

SAMPO PLC                 STOCK EXCHANGE RELEASE         18 July 2024 at 8:30 am Sampo plc’s share buybacks 17 July 2024 On 17 July 2024, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  6,344 39.49 AQEU          59,240 39.44 CEUX  1,561 39.44 TQEX  68,081 39.42 XHELTOTAL 135,226 39.44  *rounded to two decimals                 On 17 June 2024, Sampo announced a share buyback programme of up to a maximum of EUR 400 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 18 June...

Aspocomp Group Plc, Stock Exchange Release, July 18, 2024, at 8:25 a.m. Finnish time The Board of Directors of Aspocomp Group Plc has approved a new performance period covering the years 2024–2026 within the share-based long-term incentive scheme. The Performance Share Plan (also “PSP”) is part of the existing long-term incentive scheme structure, and it is aimed at the company’s top management and selected key employees. Aspocomp Group originally announced the establishment of the long-term incentive scheme with a stock exchange release issued on July 20, 2022. The next plan within the PSP structure, PSP 2024–2026, commences as of the beginning of 2024 and the share rewards potentially earned thereunder will be paid during first half of 2027. The payment of the rewards is conditional on the achievement of the performance targets set...

OSLO, Norway (July 18 2024) – TGS, a leading global provider of energy data and intelligence, is pleased to announce the extension of its’ deepwater Ocean Bottom Node (OBN) data acquisition campaign in West Africa. This additional program for a major customer will extend the ongoing acquisition cooperation well into Q4 2024. The project is expected to deliver industry leading seismic data thus providing the client with more informed decision making capabilities. Kristian Johansen, CEO at TGS, commented: “This continuing acquisition campaign demonstrates the vital role that OBN acquisition plays in providing our clients with superior seismic data. We are pleased to continue our efforts in West Africa and look forward to supporting our client’s needs with our advanced data solutions.” For more information, visit TGS.com or contact: Bård...

SHANGHAI, July 17, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (NMPA) has accepted for review the supplemental new drug application (sNDA) for toripalimab (trade name: TUOYI®, product code: JS001) combined with bevacizumab for the first-line treatment of unresectable or metastatic hepatocellular carcinoma (HCC). Liver cancer is a common malignant tumor of the digestive system worldwide, and the predominant pathological type is HCC (accounting for about 90% of global cases). According to the 2022 GLOBOCAN Report, there were 866,000 new cases and 759,000 deaths from liver cancer...

SINGAPORE, July 17, 2024 (GLOBE NEWSWIRE) — SAI.TECH Global Corporation (“SAI.TECH” or “SAI” or the “Company”) (NASDAQ: SAI, SAITW), today announced that its board of directors has authorized a new share repurchase program under which the Company may repurchase up to US$1 million and up to 1 million shares of its ordinary shares until January 11, 2025. The Company plans to adopt and implement this share repurchase program in accordance with applicable rules and requirements under the Securities Exchange Act of 1934, as amended, and the Company’s insider trading policies. The Company’s proposed repurchases may be made from time to time in the open market at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions and in accordance...

CALGARY, Alberta, July 17, 2024 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based energy transition company focused on providing stable and sustainable energy transition solutions, is pleased to announce the signing of its first LNG Framework Agreement (“Agreement”) for the utilization of liquefied natural gas (“LNG”) to fuel Kazakhstan’s rail locomotives. The Agreement was also signed by Kazakhstan Temir Zholy National Company JSC (“KTZ”), the national railway operator of the Republic of Kazakhstan (“Kazakhstan”) and Wabtec Corporation (“Wabtec”) (NYSE: WAB), a U.S. based locomotive manufacturer with existing facilities in Kazakhstan. KTZ and Wabtec previously signed a memorandum of understanding which includes modernization work to retrofit KTZ’s mainline locomotive fleet for LNG...

WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company has signed a Memorandum of Understanding (“MOU”) and License Agreement with Nuseed Nutritional US Inc. (the seed technologies platform of Nufarm Limited (ASX:NUF)), granting Nufarm a commercial license to certain Omega-3 intellectual property assets, materials and know-how for producing oil in Camelina. Nufarm and Yield10 have additionally agreed to immediately negotiate exclusively with each other for the sale of Yield10’s remaining assets to Nufarm. The asset sale will require an affirmative vote from the shareholders of Yield10, and a special meeting of shareholders will be convened to seek that vote following the execution of the asset...